Concordance of laparoscopic and laparotomic peritoneal cancer index using a two-step surgical protocol to select patients for cytoreductive surgery in advanced ovarian cancer-Reference-Cited by-同舟云学术

Concordance of laparoscopic and laparotomic peritoneal cancer index using a two-step surgical protocol to select patients for cytoreductive surgery in advanced ovarian cancer

Published:2021-01-03 Issue:5 Volume:303 Page:1295-1304
ISSN:0932-0067
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Angeles Martina Aida,Migliorelli Federico,Del Mathilde,Martínez-Gómez Carlos,Daix Manon,Bétrian Sarah,Gabiache Erwan,Balagué Gisèle,Leclerc Sophie,Mery Eliane,Gladieff Laurence,Ferron Gwénaël,Martinez Alejandra^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00404-020-05874-y.pdf

Reference34 articles.

1. Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-Rustum NR, Sonoda Y, Levine DA, Hensley M, Barakat RR (2006) What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 103:559–564. https://doi.org/10.1016/j.ygyno.2006.03.051

2. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20:1248–1259. https://doi.org/10.1200/JCO.2002.20.5.1248

3. Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, Mannel RS, DeGeest K, Hartenbach EM, Baergen R, Mackey D (2003) Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study. J Clin Oncol 21:3194–3200. https://doi.org/10.1200/JCO.2003.02.153

4. Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye AB, Oldham J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson MI (2016) Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: society of gynecologic oncology and american society of clinical oncology clinical practice guideline. Gynecol Oncol 143:3–15. https://doi.org/10.1016/j.ygyno.2016.05.022

5. NCCN, Ovarian Cancer, Humana Press, Totowa, NJ, 2013. https://doi.org/10.1007/978-1-62703-547-7

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic laparoscopy for pre-operative selection of patients with known peritoneal carcinomatosis for CRS-HIPEC: A systematic review and meta-analysis;European Journal of Surgical Oncology;2024-11

2. Assessment of Intraoperative Scoring Systems for Predicting Cytoreduction Outcome in Peritoneal Metastatic Disease: A Systematic Review and Meta-analysis;Annals of Surgical Oncology;2024-06-25

3. Delta-Peritoneal Cancer Index to Predict Complete Cytoreduction and Histopathological Response to Neoadjuvant Chemotherapy in Ovarian Cancer;2024

4. Prediction of Surgical Outcome in Advanced Ovarian Cancer by Imaging and Laparoscopy: A Narrative Review;Cancers;2023-03-22

5. Impact of pattern of recurrence on post-relapse survival according to surgical timing in patients with advanced ovarian cancer;International Journal of Gynecologic Cancer;2022-11-29